Follow The Filings

TRMD TORM

TORM earnings company data as of 4:49 AM ET 9/24

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —
FY2026 Q2 26 Aug EPS 3.90 — —
Rev — — —

Insider trades

Open-market buys and sales by TRMD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TRMD insider trades
  • None no insider bought on the open market
  • $19.2M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Kim Balle CFO
    Sale
    $1.6M 42,533 shares at $38.63 99% of stake
    Traded Sep 18–22 Filed Sep 24
  2. Kim Balle CFO
    Buy
    — 254 shares New stake
    Traded Aug 27 Filed Aug 28
  3. Jacob Balslev Meldgaard CEO
    Sale
    $17.6M 549,147 shares at $32.05 100% of stake
    Traded May 18–20 Filed May 20

Also filed in the last 12 months, not counted as buying or selling: 4 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K Period Oct 31, 2026
6-K Period Oct 31, 2026
SCHEDULE 13D/A —
6-K Period Oct 31, 2026
6-K Period Oct 31, 2026
424B7
6-K Period Oct 31, 2026
424B7
6-K Period Sep 30, 2026
SCHEDULE 13D/A —
SCHEDULE 13D/A —
6-K Period Sep 30, 2026
6-K Period Sep 30, 2026
SCHEDULE 13D/A —
SCHEDULE 13D/A —
6-K Period Sep 30, 2026
424B7
6-K Period Sep 30, 2026
424B7
6-K Period Sep 30, 2026
6-K Period Sep 30, 2026
6-K
6-K
6-K Period Aug 31, 2026
6-K Period Aug 31, 2026

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.